ALPHA TRIBE

Mankind Pharma LimitedBoard Meeting, 06-11-2025: Outcome of Board Meeting

06-11-2025 | 09:33 pm

Mankind Pharma's Board approved Q2/H1 consolidated financial results. Revenue for the quarter stood at ₹3,697.16 Cr, with profit reaching ₹520.18 Cr. A strategic update noted the ₹797 Cr Women's Health Portfolio transfer to BSV became effective Nov 1.

No comments yet. Be the first to comment!

All announcements from Mankind Pharma Limited